Lin, M., Xia, Z., Qiu, M., Chen, H., Liao, C., Huang, W., Li, H., Huang, J., Song, R., Xie, Y., Zhang, X., Liang, J., Gan, J., Guo, Y., Zhang, S. (2026). Neoadjuvant tislelizumab plus chemotherapy in MSS/pMMR high-risk locally advanced colon cancer: Updated analysis results from a phase 2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3638